Publications | Lund University Publications

41 – 46 of 46

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=issn+exact+%220167-6806%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
5
next »

2000
Mark A randomised study of sector resection with and without radiotherapy for women with node-negative stage I and II breast cancer
Malmström, P ^LU ; Wallgren, A ; Andersson, H. ; Holmberg, L ; Ingvar, C ; Jönsson, P. E. ; Mattson, J. ; Tennvall-Nittby, L and Svensson, J H (2000) In Breast Cancer Research and Treatment 64(1). p.34-34
- Contribution to journal › Published meeting abstract
1999
Mark Vascular endothelial growth factor (VEGF) and urokinase plasminogen activator (uPA) are independent prognostic factors for distant recurrence in premenopausal node-negative breast cancer
Linderholm, B. ; Gruvberger, S ^LU ; Fernö, M ^LU ; Bendahl, P-O ^LU and Malmström, Per ^LU (1999) In Breast Cancer Research and Treatment 57(1). p.98-98
- Contribution to journal › Published meeting abstract
Mark Predictive value of P53, MDM-2, P21-expression, KI-67 for response to docetaxel or methotrexate-fluorouracil (MF) in advanced breast cancer
Blomqvist, C. ; Sjöström, J ; von Boguslawski, K ; Heikkila, P ; Bengtsson, N-O ; Mjaaland, I ; Ostenstad, B ; Malmström, P ^LU ; Bergh, J. and Valvere, V , et al. (1999) In Breast Cancer Research and Treatment 57(1). p.61-61
- Contribution to journal › Published meeting abstract
Mark Predictive value c-erB-B2 expression for response to docetaxel (D) or methotrexate-fluorouracil (MF) in advanced breast cancer
Collan, J ; Sjöström, J ; von Boguslawski, K ; Franssila, K ; Bengtsson, N-O ; Mjaaland, I ; Østenstad, B ; Malmström, P ^LU ; Bergh, J. and Valvere, V , et al. (1999) In Breast Cancer Research and Treatment 57(1). p.64-64
- Contribution to journal › Published meeting abstract
1998
Mark Urokinase plasminogen activator and flow cytometric S-phase fraction as prognostic indicators in breast cancer
Fernö, M ^LU ; Bendahl, P-O ^LU and Malmström, P ^LU (1998) In Breast Cancer Research and Treatment 50(3).
- Contribution to journal › Published meeting abstract
Mark A dose intensity study of epirubicin weekly for disseminated breast cancer
Malmström, P. ^LU ; Malmberg, P ; Jönsson, P. E. ; Ingvar, C ; Loven, L and Rudenstam, CM (1998) In Breast Cancer Research and Treatment 50(3).
- Contribution to journal › Published meeting abstract

« previous
1
2
3
4
5
next »

your query:: Remove issn: 0167-6806